New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
10:00 EDTFDO, COLM, ALB, WPX, PFS, MTDR, ONE, DCO, BOH, TSN, PCYC, MWE, FGP, COST, AGNC, ZION, SBH, MSTR, LSTROn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Albemarle (ALB) upgraded to Buy from Hold at Topeka... American Capital Agency (AGNC) upgraded to Buy from Hold at Wunderlich... Bank of Hawaii (BOH) upgraded to Buy from Neutral at DA Davidson... Columbia Sportswear (COLM) upgraded to Hold from Sell at McAdams Wright... Costco (COST) upgraded to Conviction Buy from Neutral at Goldman... Ducommun (DCO) upgraded to Buy from Neutral at DA Davidson... Family Dollar (FDO) upgraded to Neutral from Underweight at Piper Jaffray... Ferrellgas Partners LP (FGP) upgraded to Neutral from Sell at Citigroup... Higher One (ONE) upgraded to Overweight from Underweight at Piper Jaffray... Landstar System (LSTR) upgraded to Buy from Hold at BB&T... MarkWest Energy (MWE) upgraded to Buy from Hold at Wunderlich... Matador (MTDR) upgraded to Outperform from Market Perform at BMO Capital... MicroStrategy (MSTR) upgraded at JMP Securities... Pharmacyclics (PCYC) upgraded to Outperform from Market Perform at Leerink... Provident Financial (PFS) upgraded at Sterne Agee... Sally Beauty (SBH) upgraded to Buy from Neutral at Citigroup... Tyson Foods (TSN) upgraded to Buy from Hold at Miller Tabak... WPX Energy (WPX) upgraded to Accumulate from Hold at Tudor Pickering... Zions Bancorp (ZION) upgraded at Bernstein.
News For ALB;AGNC;BOH;COLM;COST;DCO;FDO;FGP;ONE;LSTR;MWE;MTDR;MSTR;PCYC;PFS;SBH;TSN;WPX;ZION From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 22, 2015
08:29 EDTCOSTCostco May weekly volatility elevated into Q3 and revenue outlook
Subscribe for More Information
08:06 EDTPCYCPharmacyclics announces positive opinion from EMA for Imbruvica
Subscribe for More Information
08:00 EDTPCYCAbbVie announces expiration of HSR waiting period for Pharmacyclics acquisition
AbbVie (ABBV) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for AbbVie's purchase of Pharmacyclics (PCYC) has expired today. The expiration satisfies the exchange offer condition with respect to the approvals and clearances required under antitrust laws. Assuming that the other customary exchange offer conditions are satisfied, including a minimum tender of at least a majority of outstanding Pharmacyclics shares, it is expected that the exchange offer to acquire all of the outstanding shares of common stock of Pharmacyclics will expire today at 5:00 p.m., New York City time, without any further extension.
07:51 EDTLSTRLandstar System board increases authorized share buyback
Landstar announced that its board has increased to 3M the number of shares of its common stock that the company is authorized to purchase under its stock purchase program.
07:51 EDTLSTRLandstar System appoints Diana Murphy as non-executive Chairman of the Board
Subscribe for More Information
May 21, 2015
08:04 EDTPCYCAbbVie announces offer consideration for acquisition of Pharmacyclics
AbbVie (ABBV) announced the per share offer consideration amounts pursuant to its previously announced offer to acquire each outstanding share of common stock of Pharmacyclics (PCYC) for a mix of cash and AbbVie common stock, as described in the Registration Statement on Form S-4 filed with the SEC by AbbVie on March 23, 2015, as amended. The mixed consideration will consist of $152.25 in cash and 1.6639 shares of AbbVie common stock and, subject to proration, the all-stock consideration will consist of 3.9879 shares of AbbVie common stock.
07:44 EDTFDODollar Tree intends to close proposed Family Dollar merger in early July
Subscribe for More Information
May 20, 2015
10:00 EDTCOLMOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:07 EDTPCYCJohnson & Johnson says exploring eight new indications for Imbruvica
Imbruvica is jointly developed and commercialized by Pharmacyclics (PCYC) and Johnson & Johnson (JNJ) subsidiary Janssen Biotech. AbbVie (ABBV) is in the process of acquiring Pharmacyclics.
08:10 EDTTSNTyson Foods repeats FY15 adjusted EPS view $3.30-$3.40, consensus $3.44
Subscribe for More Information
07:25 EDTCOLMColumbia Sportswear initiated with a Market Perform at Cowen
Subscribe for More Information
May 19, 2015
17:16 EDTTSNTyson Foods awarded $194.79M government contract
Subscribe for More Information
09:58 EDTMWEOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:45 EDTMTDRMatador upgraded to Buy from Accumulate at Global Hunter
Subscribe for More Information
07:38 EDTALBAlbemarle management to meet with Deutsche Bank
Subscribe for More Information
07:15 EDTALBGoldman Sachs to hold a conference
Subscribe for More Information
07:13 EDTZIONBarclays to hold a conference
Subscribe for More Information
07:01 EDTDCODucommun receives multiyear contracts from Gulfstream
Subscribe for More Information
May 18, 2015
16:26 EDTMWEMarkWest Energy initiated with a Buy at Deutsche Bank
Target $76.
07:46 EDTCOSTAmerican Express has $850M revenue opportunity with Plenti, says Deutsche Bank
Deutsche Bank estimates the coalition loyalty/rewards program Plenti represents a $750M-$850M annual revenue opportunity for American Express (AXP) over the next 3-5 years. Earnings accretion will take time, but returns on equity are likely "very high," Deutsche says in a research note. The firm believes Plenti is an example of how Amex is leveraging its strengths to mitigate the loss of Costco (COST). It thinks Plenti's next program supplier needs to be a grocery chain, and pegs Whole Foods (WFM) as a good candidate. Deutsche keeps a Buy rating on American Express with a $90 price target.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use